Low Birth Weight and Increased Sympathetic Activity
2004; Lippincott Williams & Wilkins; Volume: 109; Issue: 5 Linguagem: Inglês
10.1161/01.cir.0000115205.70330.05
ISSN1524-4539
AutoresGünther Weitz, Horst L. Fehm, Christoph Dodt,
Tópico(s)Neonatal Respiratory Health Research
ResumoHomeCirculationVol. 109, No. 5Low Birth Weight and Increased Sympathetic Activity Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBLow Birth Weight and Increased Sympathetic Activity Gunther Weitz, Horst Lorenz Fehm and Christoph Dodt Gunther WeitzGunther Weitz Department of Internal Medicine I, University of Schleswig-Holstein, Lübeck, Germany , Horst Lorenz FehmHorst Lorenz Fehm Department of Internal Medicine I, University of Schleswig-Holstein, Lübeck, Germany and Christoph DodtChristoph Dodt Department of Internal Medicine I, University of Schleswig-Holstein, Lübeck, Germany Originally published10 Feb 2004https://doi.org/10.1161/01.CIR.0000115205.70330.05Circulation. 2004;109:e30To the Editor:In a recent study on twins, IJzerman et al1 report an association between low birth weight and a short pre-ejection period at rest and during stress tests. They interpret their findings as evidence for an increased sympathetic nervous activity in low birth weight subjects. These data elucidate an important aspect in the regulation of the sympathetic system in low birth weight subjects. However, on the background of a study of our group, which examined muscle sympathetic nerve activity (MSNA) in low birth weight singletons,2 the interpretation of the results may have to be modified. In our study, sympathetic neural activity to the muscle vascular bed was determined by specific intraneural measurement. Under resting conditions, MSNA was lower in low birth weight subjects as compared with a control group with normal birth weight. Baroreflex function was also examined and showed normal functional properties. Additionally, sympathoexcitatory maneuvers (inspiratory apnea and cold pressor test) enhanced sympathetic activity in low birth weight subjects to the same extent as in control subjects.The different results could be explained by the difference in cohorts studied. Whereas IJzerman examined monozygotic and dizygotic twins, we compared sympathetic regulation in low birth weight singletons in a case-control design. The fetal growth pattern of twins differs from that of singletons. The growth deceleration in twins occurs particularly in the last trimester of pregnancy, indicating that fetoplacental insufficiency is a major pathogenetic factor.3 In contrast, low birth weight singletons are rather affected during the whole fetal period, and maternal factors seem to play a predominant role. As indicated by results of animal studies, the effect of intrauterine growth restriction on the sympathetic nervous system depends on both the mode and the timing of the adverse event in utero.4Both the IJzerman et al1 study and our study show that intrauterine insults affect the regulation of sympathetic functions. However, the finding of an increased sympathetic activity to the heart does not automatically imply an activation of other branches of the sympathetic nervous system. In fact, one can hypothesize that baroreflex regulation is responsible for the findings of both studies. Thus, the enhanced cardiac sympathetic activity could be counterbalanced by lower sympathetic outflow to the muscle vascular bed or vice versa. The significance for developing arteriosclerotic risk factors, however, remains to be determined.1 IJzerman RG, Stehouwer CDA, de Geus EJ, et al. Low birth weight is associated with increased sympathetic activity: dependence on genetic factors. Circulation. 2003; 108: 566–571.LinkGoogle Scholar2 Weitz G, Deckert P, Heindl S, et al. Evidence for lower sympathetic nerve activity in young adults with low birth weight. J Hypertens. 2003; 21: 943–950.CrossrefMedlineGoogle Scholar3 Loos RJF, Fagard R, Beunen G, et al. Birth weight and blood pressure in young adults: a prospective twin study. Circulation. 2001; 104: 1633–1638.CrossrefMedlineGoogle Scholar4 Young JB, Morrison SF. Effects of fetal and neonatal environment on sympathetic nervous system development. Diabetes Care. 1998; 21 (suppl 2): B156–B160.MedlineGoogle ScholarcirculationahaCirculationCirculationCirculation0009-73221524-4539Lippincott Williams & WilkinsResponseIJzerman Richard G., , Stehouwer Coen D.A., , de Geus Eco J., , van Weissenbruch Mirjam M., , Delemarre-van de Waal Henriette A., , and Boomsma Dorret I., 10022004We thank Weitz et al for their comments. They argue that differences in birth weight in twins are a poor model for differences in birth weight in singletons. Of course, intrauterine growth in twins is different from that in singletons in several respects. However, the association between birth weight and blood pressure in the overall sample of twins (−1.9 mm Hg per kg increase of birth weight) was remarkably similar to the well-established association in singletons (approximately −2 mm Hg per kg increase of birth weight).1 The same holds true for the size of the association of birth weight with serum lipids2 in the overall sample of twins, which was similar to the size of the association in singletons.3 In addition, differences in birth weight within twin pairs have been associated with differences in many variables that have been related to birth weight in singletons, such as blood pressure, diabetes, serum lipids, fibrinogen, myocardial infarction and height (for references see IJzerman et al4). Although intrauterine growth in twins may be different from that in singletons, the associations between birth weight and cardiovascular risk in twins suggest that birth weight in twins is relevant for the development of cardiovascular disease and that differences in birth weight in twins can be used as a model for differences in birth weight in singletons.We agree with Weitz et al5 that an increased sympathetic activity to the heart does not automatically imply an activation of other branches of the sympathetic nervous system. They argue that, in subjects with a low birth weight, baroreflex regulation is responsible for enhanced cardiac sympathetic activity as well as lower sympathetic outflow to the muscle vascular bed. This is an intriguing and testable working hypothesis. However, sympathetic activity to the heart, as measured in our study (n=228), is probably more relevant with respect to the development of high blood pressure than sympathetic activity to the leg. Finally, in the study by Weitz et al5 (n=20), birth weight was not associated with blood pressure. This makes it questionable whether the individuals studied by Weitz et al were an "appropriate" sample to investigate potential mechanisms (such as sympathetic activity) linking birth weight to blood pressure. eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Bhunu B, Riccio I and Intapad S (2021) Insights into the Mechanisms of Fetal Growth Restriction-Induced Programming of Hypertension, Integrated Blood Pressure Control, 10.2147/IBPC.S312868, Volume 14, (141-152) Szendrey M, Guo J, Li W, Yang T and Zhang S (2021) COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels, Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.120.000484, 377:2, (265-272), Online publication date: 1-May-2021. Slade L, Cowie A, Martyniuk C, Kienesberger P and Pulinilkunnil T (2017) Dieldrin Augments mTOR Signaling and Regulates Genes Associated with Cardiovascular Disease in the Adult Zebrafish Heart ( Danio rerio ) , Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.116.239806, 361:3, (375-385), Online publication date: 1-Jun-2017. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H, Heidbuchel H, Hendriks J, Hindricks G, Manolis A, Oldgren J, Popescu B, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro J, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser S, Kolh P, Lip G, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo J, Taylor C, Van Gelder I, Voors A, Windecker S, Zamorano J and Zeppenfeld K (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Europace, 10.1093/europace/euw295, 18:11, (1609-1678), Online publication date: 1-Nov-2016. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H, Heidbuchel H, Hendriks J, Hindricks G, Manolis A, Oldgren J, Popescu B, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro J, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser S, Kolh P, Lip G, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo J, Taylor C, Van Gelder I, Voors A, Windecker S, Zamorano J and Zeppenfeld K (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, European Journal of Cardio-Thoracic Surgery, 10.1093/ejcts/ezw313, 50:5, (e1-e88), Online publication date: 1-Nov-2016. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H, Heidbuchel H, Hendriks J, Hindricks G, Manolis A, Oldgren J, Popescu B, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro J, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser S, Kolh P, Lip G, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo J, Taylor C, Van Gelder I, Voors A, Windecker S, Zamorano J and Zeppenfeld K (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, European Heart Journal, 10.1093/eurheartj/ehw210, 37:38, (2893-2962), Online publication date: 7-Oct-2016. Lieve K and Wilde A (2016) Inherited ion channel diseases: a brief review, Europace, 10.1093/europace/euv105, 17:suppl 2, (ii1-ii6), Online publication date: 1-Oct-2015. Moreno C, Oliveras A, de la Cruz A, Bartolucci C, Muñoz C, Salar E, Gimeno J, Severi S, Comes N, Felipe A, González T, Lambiase P and Valenzuela C (2015) A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome , Cardiovascular Research, 10.1093/cvr/cvv196, 107:4, (613-623), Online publication date: 1-Sep-2015. Lodder E and Bezzina C (2013) Genomics of cardiac electrical function, Briefings in Functional Genomics, 10.1093/bfgp/elt029, 13:1, (39-50), Online publication date: 1-Jan-2014. Calkins H, Kuck K, Cappato R, Brugada J, Camm A, Chen S, Crijns H, Damiano R, Davies D, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz M, Haines D, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim Y, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay B, Mansour M, Marchlinski F, McCarthy P, Mont J, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer D, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin J, Shemin R, Tsao H, Wilber D, Calkins H, Kuck K, Cappato R, Chen S, Prystowsky E, Kuck K, Natale A, Haines D, Marchlinski F, Calkins H, Davies D, Lindsay B, Damiano R, Packer D, Brugada J, Camm A, Crijns H, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz M, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jais P, Jalife J, Kalman J, Keane D, Kim Y, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Mansour M, Marchlinski F, McCarthy P, Mont J, Morady F, Nademanee K, Nakagawa H, Nattel S, Pappone C, Raviele A, Reddy V, Ruskin J, Shemin R, Tsao H, Wilber D, Ad N, Cummings J, Gillinov A, Heidbuchel H, January C, Lip G, Markowitz S, Nair M, Ovsyshcher I, Pak H, Tsuchiya T, Shah D, Siong T and Vardas P (2012) 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society, Europace, 10.1093/europace/eus027, 14:4, (528-606), Online publication date: 1-Apr-2012. Casini S and Postma A (2012) Decreased inward rectification of Kir2.1 channels is a novel mechanism underlying the short QT syndrome, Cardiovascular Research, 10.1093/cvr/cvs084, 93:4, (535-536), Online publication date: 15-Mar-2012. Hattori T, Makiyama T, Akao M, Ehara E, Ohno S, Iguchi M, Nishio Y, Sasaki K, Itoh H, Yokode M, Kita T, Horie M and Kimura T (2011) A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents, Cardiovascular Research, 10.1093/cvr/cvr329, 93:4, (666-673), Online publication date: 15-Mar-2012. Garg V, Stary-Weinzinger A, Sachse F and Sanguinetti M (2011) Molecular Determinants for Activation of Human Ether-à-go-go-related Gene 1 Potassium Channels by 3-Nitro- N -(4-phenoxyphenyl) Benzamide , Molecular Pharmacology, 10.1124/mol.111.073809, 80:4, (630-637), Online publication date: 1-Oct-2011. Cerrone M and Priori S (2011) Genetics of sudden death: focus on inherited channelopathies, European Heart Journal, 10.1093/eurheartj/ehr082, 32:17, (2109-2118), Online publication date: 1-Sep-2011. Ackerman M, Priori S, Willems S, Berul C, Brugada R, Calkins H, Camm A, Ellinor P, Gollob M, Hamilton R, Hershberger R, Judge D, Le Marec H, McKenna W, Schulze-Bahr E, Semsarian C, Towbin J, Watkins H, Wilde A, Wolpert C and Zipes D (2011) HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Europace, 10.1093/europace/eur245, 13:8, (1077-1109), Online publication date: 1-Aug-2011. Templin C, Ghadri J, Rougier J, Baumer A, Kaplan V, Albesa M, Sticht H, Rauch A, Puleo C, Hu D, Barajas-Martinez H, Antzelevitch C, Luscher T, Abriel H and Duru F (2011) Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6), European Heart Journal, 10.1093/eurheartj/ehr076, 32:9, (1077-1088), Online publication date: 1-May-2011. Cheng J, Van Norstrand D, Medeiros-Domingo A, Valdivia C, Tan B, Ye B, Kroboth S, Vatta M, Tester D, January C, Makielski J and Ackerman M (2009) α1-Syntrophin Mutations Identified in Sudden Infant Death Syndrome Cause an Increase in Late Cardiac Sodium Current, Circulation: Arrhythmia and Electrophysiology, 2:6, (667-676), Online publication date: 1-Dec-2009. Campuzano O and Brugada R (2009) Genetics of familial atrial fibrillation, Europace, 10.1093/europace/eup199, 11:10, (1267-1271), Online publication date: 1-Oct-2009. Wang D, Crotti L, Shimizu W, Pedrazzini M, Cantu F, De Filippo P, Kishiki K, Miyazaki A, Ikeda T, Schwartz P and George A (2008) Malignant Perinatal Variant of Long-QT Syndrome Caused by a Profoundly Dysfunctional Cardiac Sodium Channel, Circulation: Arrhythmia and Electrophysiology, 1:5, (370-378), Online publication date: 1-Dec-2008. Perrin M, Kuchel P, Campbell T and Vandenberg J (2008) Drug Binding to the Inactivated State Is Necessary but Not Sufficient for High-Affinity Binding to Human Ether-à-go-go -Related Gene Channels , Molecular Pharmacology, 10.1124/mol.108.049056, 74:5, (1443-1452), Online publication date: 1-Nov-2008. Barajas-Martínez H, Hu D, Cordeiro J, Wu Y, Kovacs R, Meltser H, Kui H, Elena B, Brugada R, Antzelevitch C and Dumaine R (2008) Lidocaine-Induced Brugada Syndrome Phenotype Linked to a Novel Double Mutation in the Cardiac Sodium Channel, Circulation Research, 103:4, (396-404), Online publication date: 15-Aug-2008. Hancox J and James A (2008) Refining Insights into High-Affinity Drug Binding to the Human Ether-à-go-go- Related Gene Potassium Channel: Fig. 1. , Molecular Pharmacology, 10.1124/mol.108.047563, 73:6, (1592-1595), Online publication date: 1-Jun-2008. Xu X, Recanatini M, Roberti M and Tseng G (2008) Probing the Binding Sites and Mechanisms of Action of Two Human Ether-a-go-go -Related Gene Channel Activators, 1,3-bis-(2-Hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1 H -isoindol-5-ylamino]-nicotinic acid (PD307243) , Molecular Pharmacology, 10.1124/mol.108.045591, 73:6, (1709-1721), Online publication date: 1-Jun-2008. Gordon E, Lozinskaya I, Lin Z, Semus S, Blaney F, Willette R and Xu X (2007) 2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1 H -isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human Ether-a-go-go -Related Gene Potassium Channels , Molecular Pharmacology, 10.1124/mol.107.041152, 73:3, (639-651), Online publication date: 1-Mar-2008. Hansen R, Diness T, Christ T, Wettwer E, Ravens U, Olesen S and Grunnet M (2006) Biophysical Characterization of the New Human Ether-A-Go-Go-Related Gene Channel Opener NS3623 [ N -(4-Bromo-2-(1 H -tetrazol-5-yl)-phenyl)- N ′-(3′-trifluoromethylphenyl)urea] , Molecular Pharmacology, 10.1124/mol.106.026492, 70:4, (1319-1329), Online publication date: 1-Oct-2006. Schulze-Bahr E (2005) Short QT Syndrome or Andersen Syndrome, Circulation Research, 96:7, (703-704), Online publication date: 15-Apr-2005.Priori S, Pandit S, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, Napolitano C, Anumonwo J, di Barletta M, Gudapakkam S, Bosi G, Stramba-Badiale M and Jalife J (2005) A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene, Circulation Research, 96:7, (800-807), Online publication date: 15-Apr-2005. Fossa A, Wisialowski T, Magnano A, Wolfgang E, Winslow R, Gorczyca W, Crimin K and Raunig D (2004) Dynamic Beat-to-Beat Modeling of the QT-RR Interval Relationship: Analysis of QT Prolongation during Alterations of Autonomic State versus Human Ether a-go-go -Related Gene Inhibition , Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.104.073288, 312:1, (1-11), Online publication date: 1-Jan-2005. Extramiana F and Antzelevitch C (2004) Amplified Transmural Dispersion of Repolarization as the Basis for Arrhythmogenesis in a Canine Ventricular-Wedge Model of Short-QT Syndrome, Circulation, 110:24, (3661-3666), Online publication date: 14-Dec-2004.Tomaselli G and Zipes D (2004) What Causes Sudden Death in Heart Failure?, Circulation Research, 95:8, (754-763), Online publication date: 15-Oct-2004.Arking D, Chugh S, Chakravarti A and Spooner P (2004) Genomics in Sudden Cardiac Death, Circulation Research, 94:6, (712-723), Online publication date: 2-Apr-2004.Cheng T (2004) Digitalis Administration: An Underappreciated but Common Cause of Short QT Interval, Circulation, 109:9, (e152-e152), Online publication date: 9-Mar-2004. February 10, 2004Vol 109, Issue 5 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000115205.70330.05PMID: 14769692 Originally publishedFebruary 10, 2004 PDF download Advertisement
Referência(s)